PROGNOSTIC SIGNATURE FOR COLORECTAL CANCER RECURRENCE

An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ALMAL, ARPIT, LEHEHAN, PETER, F, FRY, DAVID, W, WORZEL, WILLIAM, P
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5. La présente invention concerne un système de dosage qui est utile pour prédire la récurrence et/ou la non-récurrence d'un cancer colorectal chez un patient. Le système de dosage est conçu pour analyser un échantillon d'un patient afin d'étudier l'expression quantitative d'un profil génétique pronostique corrélé à la récurrence du cancer colorectal. Le profil comprend l'expression des séquences d'acides nucléiques des SEQ ID No. : 1, 2, 3, 4, et 5.